The Deal Register
Database › M&A › Dr. Fahar Merchant acquires shares of Medicenna

M&A

Dr. Fahar Merchant acquires shares of Medicenna

Lane
M&A
Announced
15 Dec 2025
Province
Ontario
Industry
Unclassified
Status
Announced
What the filing says
On December 15, 2025, Fahar Merchant, President and Chief Executive Officer of Medicenna Therapeutics Corp. (" Medicenna "), purchased an aggregate of 32,000 common shares of Medicenna (the " Shares ") through the facilities of the Toronto Stock Exchange at a price of $1.11 per Share, for an aggregate consideration of $35,520 (the " Transaction ").
Terms stated
price per security
Source

The terms are in the subscriber edition

This transaction carries 1 stated term, with its value, unit and basis.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe